Simon Tate
Directeur/Membre du Conseil chez ELIEM THERAPEUTICS, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Simon Tate
Sociétés | Poste | Début | Fin |
---|---|---|---|
ELIEM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2019 | - |
Independent Dir/Board Member | 01/02/2019 | - | |
Bridge Valley Ventures LLP
Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge. | Private Equity Investor | - | - |
Historique de carrière de Simon Tate
Anciens postes connus de Simon Tate
Sociétés | Poste | Début | Fin |
---|---|---|---|
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 06/10/2010 | 12/04/2018 |
Directeur Technique/Scientifique/R&D | 06/10/2010 | 12/04/2018 | |
Fondateur | - | 12/04/2018 | |
INTERMEDIATE CAPITAL GROUP PLC | Corporate Officer/Principal | - | - |
Calchan Ltd.
Calchan Ltd. BiotechnologyHealth Technology Calchan Ltd. operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain. The company was founded by Brenda Elizabeth Reynolds in 2011 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - | - |
BIOGEN INC. | Corporate Officer/Principal | - | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - | - |
Calchan Holdings Ltd.
Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Calchan Holdings Ltd. develops novel oral state-dependent calcium channel modulators for chronic pain. The company was founded on February 25, 2011 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Formation de Simon Tate
University Of Dundee | Graduate Degree |
Statistiques
Internationale
Royaume-Uni | 7 |
Etats-Unis | 3 |
Canada | 2 |
Opérationnelle
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 7 |
Finance | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
BIOGEN INC. | Health Technology |
ELIEM THERAPEUTICS, INC. | Health Technology |
INTERMEDIATE CAPITAL GROUP PLC | Finance |
Entreprise privées | 5 |
---|---|
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Calchan Holdings Ltd.
Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Calchan Holdings Ltd. develops novel oral state-dependent calcium channel modulators for chronic pain. The company was founded on February 25, 2011 and is headquartered in London, the United Kingdom. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Calchan Ltd.
Calchan Ltd. BiotechnologyHealth Technology Calchan Ltd. operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain. The company was founded by Brenda Elizabeth Reynolds in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
Bridge Valley Ventures LLP
Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge. | Finance |
- Bourse
- Insiders
- Simon Tate
- Expérience